LS Investment Advisors LLC decreased its stake in shares of Colgate-Palmolive (NYSE:CL) by 16.6% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 62,190 shares of the company’s stock after selling 12,348 shares during the quarter. LS Investment Advisors LLC’s holdings in Colgate-Palmolive were worth $4,692,000 as of its most recent filing with the SEC.
Other hedge funds also recently made changes to their positions in the company. Jacobi Capital Management LLC boosted its holdings in Colgate-Palmolive by 125.5% in the 3rd quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock valued at $104,000 after purchasing an additional 803 shares during the period. Krilogy Financial LLC boosted its holdings in Colgate-Palmolive by 23.0% in the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock valued at $115,000 after purchasing an additional 289 shares during the period. Calton & Associates Inc. bought a new stake in Colgate-Palmolive in the 4th quarter valued at about $126,000. Captrust Financial Advisors bought a new stake in Colgate-Palmolive in the 2nd quarter valued at about $122,000. Finally, AlphaMark Advisors LLC boosted its holdings in Colgate-Palmolive by 1.5% in the 2nd quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock valued at $126,000 after purchasing an additional 25 shares during the period. 72.85% of the stock is owned by institutional investors and hedge funds.
A number of analysts have issued reports on CL shares. Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 price objective for the company in a report on Monday, October 23rd. Deutsche Bank started coverage on shares of Colgate-Palmolive in a report on Wednesday, December 13th. They issued a “hold” rating and a $75.00 price objective for the company. Macquarie raised shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price objective for the company in a report on Tuesday, December 19th. Stifel Nicolaus set a $73.00 price objective on shares of Colgate-Palmolive and gave the company a “hold” rating in a report on Sunday, October 29th. Finally, Societe Generale downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 price objective for the company. in a report on Wednesday, November 29th. They noted that the move was a valuation call. Three equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have assigned a buy rating to the stock. Colgate-Palmolive has a consensus rating of “Hold” and a consensus price target of $77.71.
In related news, insider Jennifer Daniels sold 7,375 shares of the company’s stock in a transaction that occurred on Wednesday, December 13th. The shares were sold at an average price of $73.18, for a total transaction of $539,702.50. Following the completion of the transaction, the insider now directly owns 38,691 shares in the company, valued at approximately $2,831,407.38. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP John J. Huston sold 14,000 shares of the company’s stock in a transaction that occurred on Friday, February 9th. The stock was sold at an average price of $69.44, for a total transaction of $972,160.00. Following the transaction, the senior vice president now owns 100,508 shares of the company’s stock, valued at $6,979,275.52. The disclosure for this sale can be found here. Insiders sold a total of 421,019 shares of company stock valued at $30,031,097 over the last 90 days. Corporate insiders own 1.02% of the company’s stock.
Colgate-Palmolive (NYSE CL) opened at $71.46 on Friday. The company has a market cap of $62,550.87, a P/E ratio of 31.34, a PEG ratio of 2.65 and a beta of 0.75. The company has a quick ratio of 0.34, a current ratio of 0.47 and a debt-to-equity ratio of 24.42. Colgate-Palmolive has a 12-month low of $68.19 and a 12-month high of $77.91.
Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 26th. The company reported $0.75 EPS for the quarter, meeting the consensus estimate of $0.75. The company had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $3.92 billion. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period in the previous year, the company earned $0.75 EPS. sell-side analysts predict that Colgate-Palmolive will post 3.18 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Thursday, February 15th. Stockholders of record on Tuesday, January 23rd were given a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 2.24%. The ex-dividend date was Monday, January 22nd. Colgate-Palmolive’s payout ratio is presently 70.18%.
COPYRIGHT VIOLATION NOTICE: “Colgate-Palmolive (CL) Shares Sold by LS Investment Advisors LLC” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of United States & international copyright & trademark law. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2018/02/18/colgate-palmolive-cl-shares-sold-by-ls-investment-advisors-llc-2.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.